Genfit (Genfit) Price-to-Operating-Cash-Flow : (As of Jun. 21, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Genfit Price-to-Operating-Cash-Flow?

As of today (2024-06-21), Genfit's share price is $3.88. Genfit's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Hence, Genfit's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Genfit's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Genfit's highest Price-to-Operating-Cash-Flow Ratio was 2.48. The lowest was 1.71. And the median was 2.00.

GNFT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.45
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Genfit's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 23.40% per year.

During the past 13 years, Genfit's highest 3-Year average Operating Cash Flow per Share Growth Rate was 23.40% per year. The lowest was -200.00% per year. And the median was -8.30% per year.

Genfit Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Genfit's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genfit Price-to-Operating-Cash-Flow Chart

Genfit Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

2.40

Genfit Quarterly Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Genfit's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Genfit's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genfit's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genfit's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genfit's Price-to-Operating-Cash-Flow falls into.

Genfit Price-to-Operating-Cash-Flow Calculation

Genfit's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	3.88	/	0
	=

Genfit's Share Price of today is $3.88.
Genfit's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Genfit Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Genfit's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Genfit (Genfit) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (NAS:GNFT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

GNFTF:USA 0QT6:UK GNFT:France XUP:Germany

Address

Parc Eurasante, 885, Avenue Eugene Avinee, Loos, FRA, 59120

Website

https://www.genfit.com

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.